InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,207.20
(
-0.27%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
-0.72%
)
Bitcoin
64,114.59
(
-1.09%
)
Post# of 647871
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

kajulie

Send PM Follow Ignore
Followers 468
Posts 14028
Boards Moderated 1
Alias Born 05/07/2009

kajulie

Re: $oldier Hard post# 361726

Wednesday, 02/24/2016 12:07:50 PM

Wednesday, February 24, 2016 12:07:50 PM

Post# of 647871
IPCI waiting for PR on this!

FDA HomeDrug DatabasesOrange Book
-
Search results from the "OB_Rx" table for query on "204511."

Active Ingredient: LEVETIRACETAM
Dosage Form;Route: TABLET, EXTENDED RELEASE;ORAL
Proprietary Name: LEVETIRACETAM
Applicant: INTELLIPHARMACEUTICS
Strength: 500MG
Application Number: A204511
Product Number: 001
Approval Date: Feb 23, 2016
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code: AB
Patent and Exclusivity Info for this product: View
Active Ingredient: LEVETIRACETAM
Dosage Form;Route: TABLET, EXTENDED RELEASE;ORAL
Proprietary Name: LEVETIRACETAM
Applicant: INTELLIPHARMACEUTICS
Strength: 750MG
Application Number: A204511
Product Number: 002
Approval Date: Feb 23, 2016
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code: AB
Patent and Exclusivity Info for this product: View
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up